Avaxia Biologics Nets $6.4M

Cherrystone Angels led a $6.4 million round in Avaxia Biologics, a Massachusetts-based clinical-stage biopharma company. Golden Seeds, the Beta Fund, Granite State Angels, the Keiretsu Forum, and Maine Angels, all new investors, and existing backers Beacon Angels, Boston Harbor Angels, Launchpad Venture Group, Mass Medical Angels and North Country Angels all participated in the round.

North AmericaUSBriefs